Mechanistic Decoding of Pharmacodynamic Intratumoral Heterogeneity: A Pan-Cancer Regulatory Framework
Intratumoral heterogeneity (ITH) drives therapy failure through divergent drug response propensities among coexisting subclones - a phenomenon we term phar